David Fairman
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- Adenosine and Purinergic Signaling 3
- Genetics 4
- Glioma Diagnosis and Treatment 3
- Co-authors
- Brian ZenoAndrew I. BayliffeRichard HallJuan J. RoncoTracey J. WrightAili L. LazaarJason D. ChristieGermain Poirier
- Journals
- Journal of the American Geriatrics Society (5 papers)Stereotactic and Functional Neurosurgery (5 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Cancer (1 paper)International Journal of Cardiology (1 paper)
- Partner nations
- United KingdomUnited StatesArgentina
In The Last Decade
David Fairman
34 papers receiving 943 citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Infectious Diseases 356
- Neurology 143
- Cardiology and Cardiovascular Medicine 187
- Computational Theory and Mathematics 74
- Pharmacology 36
Countries citing papers authored by David Fairman
This map shows the geographic impact of David Fairman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fairman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fairman more than expected).
Fields of papers citing papers by David Fairman
This network shows the impact of papers produced by David Fairman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fairman. The network helps show where David Fairman may publish in the future.
Co-authors
The 25 scholars most cited alongside David Fairman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2022 | 60 | |
| 3 | 2018 | 45 | |
| 4 | A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome Hit paper breakdown → | 2017 | 452 |
| 5 | 2014 | 21 | |
| 6 | 2012 | 31 | |
| 7 | 2012 | 6 | |
| 8 | 2011 | 22 | |
| 9 | 2011 | 5 | |
| 10 | 2008 | 8 | |
| 11 | 2008 | 16 | |
| 12 | Examining the relationship between ANXIETY DISORDERS and DEPRESSION | 2007 | 1 |
| 13 | 2007 | 24 | |
| 14 | 2004 | 2 | |
| 15 | 1994 | 10 | |
| 16 | 1973 | 7 | |
| 17 | 1970 | 5 | |
| 18 | Roentgenologic principles of a new stereotaxic apparatus. | 1959 | 6 |
| 19 | 1956 | 2 | |
| 20 | 1956 | 3 |
About David Fairman
David Fairman is a scholar working on Physiology, Genetics, Transplantation, Pharmacology and Neurology, having authored 37 papers that have together received 975 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Glioma Diagnosis and Treatment (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), Adenosine and Purinergic Signaling (3 papers), Receptor Mechanisms and Signaling (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Pituitary Gland Disorders and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (356 citations), Neurology (143 citations), Cardiology and Cardiovascular Medicine (187 citations), Computational Theory and Mathematics (74 citations) and Pharmacology (36 citations). David Fairman has collaborated with scholars based in United Kingdom, United States and Argentina. Frequent co-authors include Brian Zeno, Andrew I. Bayliffe, Richard Hall, Juan J. Ronco, Tracey J. Wright, Aili L. Lazaar, Jason D. Christie, Germain Poirier, Kelly Hardes and Akram Khan. Their work appears in journals such as Journal of the American Geriatrics Society, Stereotactic and Functional Neurosurgery, Bioorganic & Medicinal Chemistry Letters, Cancer and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.